Toronto, Ontario – December 18, 2024 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Company”), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce Ventripoint and ASCEND Cardiovascular, a leading provider of cardiovascular IT solutions, have signed a term sheet defining the general terms and conditions for a non-exclusive license to Ventripoint’s VMS+ proprietary technology. The two parties expect [...]
In a landscape where healthcare IT is evolving at lightning speed, pediatric cardiology has been left behind, forced to make do with outdated, one-size-fits-all solutions. While the adult cardiovascular space has enjoyed the luxury of high-tech workflow solutions designed specifically for its unique needs, pediatric cardiology has struggled to catch up. It’s time to call [...]
Cardiac nuclear medicine offers critical value in managing heart disease by providing precise, non-invasive imaging that helps assess blood flow, detect blockages, and evaluate heart function. These insights guide treatment decisions, monitor therapy effectiveness, and improve patient outcomes, making it an essential tool in optimizing heart disease care. In high-stakes environments like cardiac care, efficient […]
Radiology is frequently at the heart of the diagnostic process, providing essential insights that guide treatment decisions across nearly all areas of patient care. However, radiologists face significant challenges that limit their ability to deliver these insights efficiently and consistently. A major issue is the ongoing radiologist shortage, which restricts the service line’s capacity and [...]
Toronto, Ontario – The Newswire – July 10, 2024 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is pleased to announce Ventripoint and ASCEND Cardiovascular, LLC a leading provider of cardiovascular IT solutions, have renewed and expanded the scope of their letter of intent. The two companies are collaborating in joint research and [...]
CEO, Dr. Jeff Soble joins DAIC to discuss the forecast for telepresence and AI in hospitals. In this interview, he discusses how these technologies allow remote specialists and care team members to “be there, without being there” by creating a live, immersive, and information-rich environment for virtual, multi-disciplinary collaboration. By combining state-of-the-art virtual communication technologies [...]
[Chicago, IL January 16,2023] – ASCEND Cardiovascular’s newest technology, Catalyst LIVE, currently implemented at two pioneering hospital sites, has pilots underway since 2022 at Stanford Medicine Children’s Health in California and Cook County Health in Illinois. Catalyst LIVE has prompted the expansion of this innovative technology into additional areas and campuses at these pilot sites [...]
Highlights of agreement ASCEND’s IT software is used by 50,000 hospitals, clinics, and caregivers. Initial two-year term for North American markets. Ventripoint will be integrated into ASCEND’s IT for cardiovascular care. Toronto, Ontario – December 12, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV: VPT; OTC: VPTDF), now bringing its AI-powered heart-scanning technology [...]
Toronto, Ontario – The Newswire – August 18, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and ASCEND Cardiovascular, LLC have developed a new integrated product. Today’s announcement marks a significant milestone in Ventripoint’s commitment to the collaboration between the two companies. ASCEND fits perfectly into [...]
Toronto, Ontario – The Newswire – August 10, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) is thrilled to announce that Ventripoint and Ascend Cardiovascular, a leading provider of cardiovascular IT solutions, have solidified a strategic collaboration. The two companies have signed a letter of intent to explore joint research and development [...]
